The predictive value of circulating lymphocyte subpopulation characteristics for the prognosis of patients with stage III–IV non-small cell lung cancer treated with EGFR-TKI
Circulating lymphocyte subsets were associated with the therapeutic effect of stage III-IV NSCLC patients treated with EGFR-TKI and can be used as a prognostic indicator of PFS in patients treated with EGFR-TKI, but a comprehensive assessment should be made in combination with clinical factors (such as stage and TKI generation).
Authors
- Jianhua Jin
- Liqun Liang (ORCID: https://orcid.org/0000-0001-5087-1769)
- Qiongqiong Zhang (ORCID: https://orcid.org/0000-0003-3565-9078)
- Yujun Han
- Bin Han (ORCID: https://orcid.org/0009-0007-4828-1437)
Institutions
- Shanxi Medical University (CN)
- Guangzhou Women and Children Medical Center (CN)
- First Hospital of Shanxi Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- BioMedical Engineering OnLine
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1186/s12938-025-01464-8
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00